Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,470.00    50.00 (2.07%)
Bid:
2,466.00
Ask:
2,470.00
Spread: 4.00 (0.162%)
Market Cap: £7.93b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

24 Jun 2025 07:00

RNS Number : 0410O
Bunzl PLC
24 June 2025
 

24 June 2025

 BUNZL PRE-CLOSE STATEMENT

Trading in-line with expectations; acquisition agreed in Brazil

 

Bunzl plc, the specialist international distribution and services Group, is updating the market today prior to entering its closed period for the six months ending 30 June 2025.

Group revenue over the period is expected to be approximately 4% higher than the prior year, at constant exchange rates, and up to 1% higher at actual exchange rates. Group revenue growth at constant exchange rates is expected to be driven by acquisitions, net of disposals, and with broadly flat underlying revenue over the period1. We expect Group operating margin over the period to be in-line with previously published guidance at around 7.0%, with the expected Group adjusted operating profit decline also in-line with expectations.

2025 guidance

As per our statement on 16th April, the Group expects moderate revenue growth in 2025, at constant exchange rates, driven by announced acquisitions and broadly flat underlying revenue. Group operating margin for the year is expected to be moderately below 8.0%, compared to 8.3% in 2024. The Group's second half operating margin is seasonally higher and expected to benefit from actions taken.

Capital allocation update

In May, Bunzl signed an agreement to acquire Solupack, a Brazilian distributor of own brand packaging solutions to the food industry. In 2024 the business generated revenue of BRL 106 million (c.£ 15 million), and alongside our existing business will enhance our offering to customers. The acquisition is subject to competition authority clearance.

At the end of June we expect our leverage to be around 2.0 times, consistent with our aim to be towards the lower end of our target range of 2.0 to 2.5 times adjusted net debt to EBITDA by the end of 2025, after potential acquisition spend.

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

"Alongside a macroeconomic backdrop that remains uncertain, the Group is trading in-line with our expectations. Actions are underway to improve performance in the Group, particularly in our largest business in North America and in Continental Europe, and we anticipate improvement in the second half of the year.

I am also pleased to welcome Solupack to the Bunzl family today, our third acquisition of the year, with our pipeline remaining active. The Group's compounding growth strategy and resilient business model underpin Bunzl's long-term track record of delivery and the Group continues to be well placed to navigate periods of macroeconomic uncertainty given our focus on essential products, the depth of our customer and supplier relationships and our sector and geographic diversification."

Enquiries:

 Bunzl plc

 Frank van Zanten, Chief Executive Officer

 Richard Howes, Chief Financial Officer

 Sunita Entwisle, Head of Investor Relations and Communications

 Tel: +44 (0)20 7725 5000

Teneo

Martin Robinson

Giles Kernick

Tel: +44 (0)20 7353 4200

1. The impact of fewer trading days is also expected to have a slight impact on revenue.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUGDLIXDDGUX
Date   Source Headline
3rd May 201610:50 amRNSBlock listing Interim Review
20th Apr 20162:40 pmRNSResult of AGM
20th Apr 20167:00 amRNSTrading Statement
14th Apr 20164:59 pmRNSDirector/PDMR Shareholding
11th Apr 20164:32 pmRNSDirector/PDMR Shareholding
6th Apr 201612:05 pmRNSDirector/PDMR Shareholding
6th Apr 201611:32 amRNSDirector/PDMR Shareholding
1st Apr 20161:48 pmRNSTotal Voting Rights
31st Mar 20164:39 pmRNSDirector/PDMR Shareholding
31st Mar 201612:05 pmRNSDirector Declaration
29th Mar 20162:49 pmRNSDirector/PDMR Shareholding
23rd Mar 20164:50 pmRNSDirector/PDMR Shareholding
23rd Mar 201612:11 pmRNSAdditional Listing
17th Mar 20163:05 pmRNSAnnual Financial Report
15th Mar 20164:32 pmRNSDirector/PDMR Shareholding
14th Mar 20164:49 pmRNSDirector/PDMR Shareholding
11th Mar 20164:59 pmRNSDirector/PDMR Shareholding
4th Mar 20162:55 pmRNSDirector/PDMR Shareholding
3rd Mar 20161:37 pmRNSDirector/PDMR Shareholding
2nd Mar 20164:51 pmRNSDirector/PDMR Shareholding
1st Mar 20164:58 pmRNSDirector/PDMR Shareholding
1st Mar 20164:57 pmRNSDirector/PDMR Shareholding
1st Mar 201612:39 pmRNSTotal Voting Rights
29th Feb 20161:09 pmRNSDividend Declaration
29th Feb 20167:00 amRNSFinal Results
29th Feb 20167:00 amRNSAcquisition
3rd Feb 20162:35 pmRNSDirector/PDMR Shareholding
1st Feb 201612:10 pmRNSTotal Voting Rights
18th Jan 201611:46 amRNSDirector Declaration
14th Jan 20167:00 amRNSDirectorate Change
13th Jan 20169:56 amRNSDirector/PDMR Shareholding
6th Jan 20164:03 pmRNSDirector/PDMR Shareholding
4th Jan 20161:51 pmRNSTotal Voting Rights
16th Dec 20157:00 amRNSTrading Statement
4th Dec 20159:50 amRNSDirector/PDMR Shareholding
1st Dec 20153:43 pmRNSTotal Voting Rights
30th Nov 20152:31 pmRNSHolding(s) in Company
9th Nov 20154:42 pmRNSDirector/PDMR Shareholding
6th Nov 20157:00 amRNSAcquisition
4th Nov 20154:28 pmRNSDirector/PDMR Shareholding
4th Nov 201512:42 pmRNSAdditional Listing
2nd Nov 201510:50 amRNSBlocklisting Interim Review
2nd Nov 201510:45 amRNSTotal Voting Rights
22nd Oct 20159:55 amRNSDirector/PDMR Shareholding
21st Oct 20157:00 amRNSTrading Statement
15th Oct 20159:13 amRNSHolding(s) in Company
9th Oct 20154:46 pmRNSDirector/PDMR Shareholding
8th Oct 20154:07 pmRNSDirector/PDMR Shareholding
7th Oct 20153:48 pmRNSDirector/PDMR Shareholding
6th Oct 20154:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.